Phase II study of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and transesophageal bronchoscopic ultrasound-guided fine needle aspiration (TEBUS-FNA) using an EBUS bronchoscope in the mediastinal staging of non-small cell lung cancer

Phase II study of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and transesophageal bronchoscopic ultrasound-guided fine needle aspiration (TEBUS-FNA) using an EBUS bronchoscope in the mediastinal staging of non-small cell lung cancer - EBUS-TBNA and TEBUS-FNA for mediastinal staging

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002882

Enrollment

140

Registered

2009-12-12

Start date

2009-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

EBUS-TBNA and TEBUS-FNA for patients with non-small cell lung cancer

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with potentially operable, suspected or proven non-small cell lung cancer 2. 20 years old or more 3. Informed consent

Exclusion criteria

Exclusion criteria: 1. Patients with recurrent lung cancer 2. Bleeding tendency 3. Pregnant woman 4. Other clinical difficulties in this study

Design outcomes

Primary

Measure	Time frame
1. Accuracy of EBUS-TBNA and/or TEBUS-FNA	—

Secondary

Measure	Time frame
1. Accuracy of non-invasive modalities (PET, CT) 2. Time of procedure 3. Frequency of adverse effects	—

Countries

Japan

Contacts

Public ContactMasahide Oki

Nagoya Medical Center Department of Respiratory Medicine

masahideo@aol.com052-951-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026